Significant incidence of type 2 diabetes on high-risk Spanish population.: The IGT Study (2)

被引:9
作者
Costa, B
Piñol, JL
Martín, F
Donado, A
Castell, C
机构
[1] Direcc Atenc Primaria Reus Tarragona, Inst Catala Salut, Tarragona, Spain
[2] Hosp Mora dEbre, Unidad Diabet, Grp Sagessa, Tarragona, Spain
[3] Direcc Gen Salud Publ, Consell Asesor Diabet Catalunya, Barcelona, Spain
来源
MEDICINA CLINICA | 2002年 / 118卷 / 08期
关键词
diabetes; incidence; screening; impaired glucose tolerance; impaired fasting glucose;
D O I
10.1016/S0025-7753(02)72362-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: Our purpose was to estimate the incidence of type 2 diabetes among a high risk population with or without impaired glucose tolerance (IGT), analysing the progression to diabetes. PATIENTS AND METHOD: Multicenter cohort study on high risk individuals without diabetes (WHO-85 criteria) in primary health care. Subjects underwent an oral glucose tolerance test measuring fasting plasma glucose (FPG) and plasma glucose at 2 hours (2hPG). Mean follow-up was 37.2 months (4.3-69.7). Phenotypic features, diagnostic variation, diabetes incidence and predictive factors (multivariate analysis and Cox proportional hazards model) were assessed. RESULTS: We included 243 individuals (148 females), aged 59.7 (10) years, with FPG < 7.8 MM and 2hPG < 11.1 mM. 137 IGT subjects (56.4%) and 106 (43.6%) normal glucose tolerance (NGT) subjects with a similar risk factor impact were evaluated. After the study was closed, 63 (25.9%) subjects developed diabetes: 43 (31.4%) with baseline IGT and 20 (18.9%) with NGT. Overall diabetes incidence increased over time but not proportionally. Mean annual incidence was 9.2% and it dropped to 4.6% when FPG was used as the unique diagnosis criterion (ADA-97). Male under 65 years with both overweight and IGT reported the highest incidence. HbA1c, FPG and 2hPG were independent predictors. Increased HDL cholesterol showed a protective effect on diabetes incidence. The IGT diagnosis interval was a much better predictor [OR = 2.06 (1.56-2.72)] of diabetes development than the impaired FPG diagnosis interval [OR = 1.37 (0.93-2.04)]. CONCLUSIONS: FPG predicted but undervalued diabetes incidence in high risk population. The IGT (2hPG) diagnosis interval predicted diabetes development better than the impaired fasting plasma glucose diagnosis interval. Increased diabetes incidence in high risk Spanish population, particulary with regard to IGT, means that primary preventive resources should be increased.
引用
收藏
页码:287 / 293
页数:7
相关论文
共 44 条
  • [11] Costa B, 2001, Aten Primaria, V28, P193
  • [12] Costa B, 1998, Aten Primaria, V22, P71
  • [13] Impact of the American Diabetes Association diagnosis criteria on high-risk Spanish population
    Costa, B
    Franch, J
    Martín, F
    Morató, J
    Donado, A
    Basora, J
    Daniel, J
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 1999, 46 (01) : 75 - 81
  • [14] Undiagnosed diabetes and impaired glucose metabolism on high-risk Spanish population.: The IGT Study
    Costa, B
    Martín, F
    Donado, A
    Parera, F
    Piñol, JL
    Basora, J
    Daniel, J
    [J]. MEDICINA CLINICA, 2000, 114 (16): : 601 - 608
  • [15] Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population - The Hoorn study
    de Vegt, F
    Dekker, JM
    Jager, A
    Hienkens, E
    Kostense, PJ
    Stehouwer, CDA
    Nijpels, G
    Bouter, LM
    Heine, RJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (16): : 2109 - 2113
  • [16] The fasting hyperglycaemia study: II. Randomized controlled trial of reinforced healthy-living advice in subjects with increased but not diabetic fasting plasma glucose
    Dyson, PA
    Hammersley, MS
    Morris, RJ
    Holman, RR
    Turner, RC
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (12): : 50 - 55
  • [17] Predictors of progression from impaired glucose tolerance to NIDDM - An analysis of six prospective studies
    Edelstein, SL
    Knowler, WC
    Bain, RP
    Andres, R
    BarrettConnor, EL
    Dowse, GK
    Haffner, SM
    Pettitt, DJ
    Sorkin, JD
    Muller, DC
    Collins, VR
    Hamman, RF
    [J]. DIABETES, 1997, 46 (04) : 701 - 710
  • [18] Franch Nadal J, 1992, Med Clin (Barc), V98, P607
  • [19] Freeman DJ, 2001, CIRCULATION, V103, P357
  • [20] The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes
    Gabir, MM
    Hanson, RL
    Dabelea, D
    Imperatore, G
    Roumain, J
    Bennett, PH
    Knowler, WC
    [J]. DIABETES CARE, 2000, 23 (08) : 1108 - 1112